Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro

Qiang Huang(Ministry of Education of the People's Republic of China), Qing Lan(National Institutes of Health), Aidong Wang(Wenzhou Medical University), Yinyan Wu(Soochow University), Jun Dong(TEDA International Cardiovascular Hospital), Yuntian Shen(Nantong University), Yi Diao(Soochow University), Yu-de Zhu(Soochow University), Yaodong Zhao(Soochow University), Quanbin Zhang(Tongji University)
BMC Cancer
October 22, 2008
Cited by 108


Related Papers